Wednesday, October 28, 2026Eastern Time · Updated through the dayRSS

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

HHS to allow sale of unapproved peptides under review

DO

By Daniel Okafor · Regulatory Correspondent

Oct 28 15:18 ETSource: The Hill

From the source

HHS to allow sale of unapproved peptides under review

Read at thehill.com

Source URL https://thehill.com/policy/healthcare/6178382-hhs-peptides-compounding-pharmacies-maha-agenda/

Prescribed peptides from $99/moSee all →